Christine Ocampo

Affiliations

  • Pao; Cao/Urovant Sciences,Inc. at Urovant Sciences Ltd. (UROV), 2021-03-31
  • See Remarks at Novus Therapeutics Inc. (NVUS), 2017-05-26
  • Vice President, Finance at Avanir Pharmaceuticals Inc. (AVNR), 2014-12-19
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NVUS $9.99 10,010 $99,999.90 21,590 2017-05-10 Filing
AVNR $2.60 3,000 $7,794.90 3,000 2012-03-06 Filing
AVNR $0.44 10,900 $4,796.00 69,400 2009-02-24 Filing
AVNR $0.42 1,000 $420.00 58,500 2009-02-24 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AVNR $16.93 5,780 $97,855.40 108,797 2014-12-18 Filing
AVNR $16.94 17,500 $296,450.00 114,577 2014-12-16 Filing
AVNR $16.94 12,500 $211,750.00 132,077 2014-12-16 Filing
AVNR $11.81 2,080 $24,564.80 77,791 2014-10-24 Filing
AVNR $9.45 55,000 $519,750.00 79,871 2014-09-15 Filing